What is it?
What St John's Wort is
1St John's Wort is the flowering herb Hypericum perforatum, sold in whole-herb and extract preparations. Its clinical research is mainly in people with depression; those findings do not establish general focus or productivity enhancement.
Names, aliases and forms
Potential effects and evidence map
Standardized extracts have patient-specific mood evidence, with results varying by extract, country, study quality and comparator. That research does not establish routine healthy-user benefits. Medication studies and official safety sources document reduced exposure to some medicines and serious reactions with serotonin-affecting drugs.
St John's Wort has human evidence in specific mood/depression research contexts, but this should not be generalized to routine wellness use or mixed with antidepressants.
A reliable calm or relaxation benefit in generally healthy adults has not been established.
Current human clinical evidence does not establish a focus or productivity benefit in generally healthy users.
Typical dosages and timing
The EMA monograph lists these daily amounts for some oral dry extracts, with other amounts for different preparations. They are medicinal-product context, not a universal whole-herb dose or a self-directed regimen.
Match the botanical name and plant part, extraction solvent and ratio, and disclosed hypericin and hyperforin amounts. Equal capsule or powder mass does not establish equivalent extracts. A certificate of analysis (COA) describes testing for a particular batch.
Timing & effect horizon
The clinical evidence comes from repeated-dose depression studies. A study course does not establish a healthy-user onset, a single-dose effect duration, or a recommended cycle.
EMA reports a hypericin plasma peak at 4-12 hours and an elimination The time for blood levels to fall by half during the final elimination phase.Source of about 19-36 hours. These describe one constituent in studied preparations, not a whole-extract half-life or the onset and duration of a nootropic benefit.
Safety, side effects and risk profile
Documented drug interactions can be serious or life-threatening, including reduced effectiveness of critical medicines and dangerous serotonergic combinations.
Human evidence is extract- and context-specific; product labels are not interchangeable with clinical-trial extracts.
Fatigue and dizziness are reported; adequate driving-performance studies are lacking.
Headache and dizziness can occur. GI upset and sunlight-related skin reactions are additional tolerability concerns.
Pregnancy and lactation safety is not established; the EMA monograph does not recommend use in these populations.
As checked in October 2026, U.S. dietary-supplement and EU herbal-medicinal-product frameworks differ; neither implies a single worldwide authorization.
In adults taking no medicines, oral use for up to 12 weeks is generally well tolerated. Reported effects include stomach upset, dizziness, restlessness and sleep disturbance. Sunlight-related skin reactions are a concern, especially with high doses. Longer-term and product-specific safety are less certain.
Interactions and cautions
Combining the herb with medicines that affect serotonin can produce serious serotonin-related toxicity, including serotonin syndrome. This risk is distinct from evidence for a mood benefit.
The herb can increase the activity of drug-metabolizing enzymes and the P-glycoprotein transporter, lowering exposure to some medicines. Hyperforin content affects interaction potential; a low-hyperforin label does not establish compatibility with all medicines.
Legal and regulatory status
As checked in October 2026, St John's Wort is marketed under the U.S. dietary-supplement framework, which does not provide FDA premarket approval of supplements for safety and effectiveness. The EU EMA/HMPC monograph concerns specified herbal medicinal preparations; national product authorizations and permitted claims vary. Neither framework establishes worldwide legal status.
Practical buying and quality notes
- Compare equivalent extract specifications before price per gram or capsule. Check stated amounts of hypericin and hyperforin and whether a batch-specific COA identifies the botanical and tests contaminants. A cheaper unit price does not establish matching composition or medication compatibility.5
- For capsules, compare the stated extract mass per capsule and capsule count. For powders, compare verified net mass and serving size. A 300 mg serving from a whole-herb powder is not automatically equivalent to 300 mg of a standardized extract. Shipping and regional availability also affect final cost. Verify the package weight and price on the merchant page, especially when a normalized cost appears implausibly low.
FAQ
Does St John's Wort work as a nootropic?
3Human findings in people with depression do not establish a general nootropic effect in healthy adults. Evidence for focus, memory and acute performance remains insufficient.
What St John's Wort dosage has been studied?
5The compact dosage field describes selected dry-extract daily amounts in the EMA monograph. Other preparations use different doses. Trial or monograph dosing cannot be transferred to an arbitrary product from its mass alone.
How long does St John's Wort take to work?
2There is no established healthy-user focus-onset or effect-duration estimate. Depression-study courses and measured blood concentrations of constituents answer different questions; neither defines a nootropic cycle.
What should I check before buying St John's Wort?
1Check the botanical identity, extract specification and disclosed constituent amounts. Compare verified serving and package sizes and batch testing. Medication interactions remain a separate concern even when a product has a clear label and COA.
References
- NCCIH. St. John's Wort: Usefulness and Safety.
- NCCIH. St. John's Wort and Depression: In Depth.
- Linde K, et al. St John's wort for major depression. Cochrane Database Syst Rev. 2008;(4):CD000448.
- Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. St John's wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol. 2002;54(4):349-356.
- EMA/HMPC. Hyperici herba - herbal medicinal product: European Union herbal monograph.
- Asher GN, Corbett AH, Hawke RL. Common herbal dietary supplement-drug interactions. Am Fam Physician. 2017;96(2):101-107.
- U.S. Food and Drug Administration. FDA 101: Dietary Supplements. Accessed 19 October 2026.